ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael Frenken
Arno Krian
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frenken, M.
Right arrow Articles by Krian, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frenken, M.
Right arrow Articles by Krian, A.

Ann Thorac Surg 1999;68:887-893
© 1999 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Cardiovascular operations in patients with dialysis-dependent renal failure

Michael Frenken, MDa, Arno Krian, MDa

a Department of Thoracic and Cardiovascular Surgery, Heart Center Duisburg, Duisburg, Germany

Address reprint requests to Dr Frenken, Chirurgische Abteilung, Städtisches Krankenhaus Düsseldorf-Gerresheim, Gräulingerstrasse 120, 40625 Düsseldorf, Germany


    Abstract
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 
Background. Cardiac operations in patients with end-stage renal disease carry a significantly increased perioperative risk, and long-term functional results and survival are still purely defined.

Methods. Therefore, we performed a retrospective analysis of 45 consecutive patients with dialysis-dependent renal failure who underwent either coronary artery bypass grafting (n = 30), valve replacement or combined procedures (n = 13), or pericardiotomy (n = 2). Mean age of the patients was 59 ± 10 years.

Results. There were two perioperative deaths (30-day mortality, 4.4%). Actuarial survival rates at 1, 2, 3, and 5 years were 0.90, 0.73, 0.67, and 0.67, respectively, after bypass operation and 0.77, 0.77, 0.77, and 0.39, respectively, after valvular or combined operation. Late deaths (n = 13) occurred 2 to 60 months after operation and were attributable to cardiac events in 7 patients. Of the long-term survivors after either bypass grafting (n = 20) or a valvular or combined procedure (n = 8), 15 and 7 patients had improved anginal status and New York Heart Association functional status, respectively, after 36 ± 4 months (range, 21 to 66 months). Five patients underwent renal transplantation 32 ± 9 months after cardiac operation.

Conclusions. Cardiac operations in patients with end-stage renal disease may be performed with a fairly low perioperative risk and the perspective of long-term functional improvement and acceptable long-term survival.


    Introduction
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 
Myocardial infarction and other cardiac events are the leading causes of mortality in the population of patients who are on maintenance dialysis due to end-stage renal disease [1]. Both for functional and for vital reasons a cardiac operation is often considered necessary to improve life quality and prolong life expectancy, especially in patients suffering from coronary artery disease [16], valvular stenosis [6, 7] or acute endocarditis [3, 8]. However, the perioperative risk from cardiovascular intervention has been significantly increased compared to the general cardiac patient population [9], and long-term survival has been relatively low [2, 6]. These poor results have been attributed to a multitude of coexisting noncardiac disorders [1, 10], to the pathologic consequences of the renal disease and dialysis-inclusive infective endocarditis [3] and to advanced cardiac disease [1].

Recent studies show considerable improvement of perioperative and long-term survival in relatively small series of well-selected patients [1, 6, 11]. Particularly, congestive heart failure class IV according to the New York Heart Association (NYHA) [6] and severely reduced left ventricular function (ejection fraction < 30%) [9] have been identified as predictors of early and late mortality. In spite of these promising results regarding short-term and long-term survival little information is available concerning long-term functional status.

The goal of the present retrospective study was a detailed analysis of our experience with cardiac operations in patients with dialysis-dependent renal disease with respect to early mortality and morbidity and with special attention to long-term survival and long-term changes in anginal status and NYHA status.


    Patients and methods
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 
This retrospective study consists of 45 consecutive patients with end-stage renal disease undergoing a cardiac procedure in our clinic between November 1989 and September 1994. All patients received either hemodialysis (n = 44) or chronic ambulatory peritoneal dialysis (n = 1) for at least 1 month before operation. The cardiac disease leading to the operation was coronary artery disease (CAD) in 31 patients, and valvular disease in 14 patients. In 2 patients (one out of each group) severe calcification of the aorta was detected after pericardiotomy. Cannulation and operation on the ascending aorta were considered to be too dangerous and installment of cardiopulmonary bypass was rejected. One of these 2 patients suffering from CAD and a symptomatic high-grade internal carotid artery stenosis was assigned to a combined procedure initially, but only a thrombendarterectomy with patch plasty of the internal carotid artery was performed. In the second patient the chest was closed without any definite cardiovascular procedure. Some demographic details of the patients are given in Table 1.


View this table:
[in this window]
[in a new window]
 
Table 1. Patient Profile

 
Preoperative patient characteristics
Tables 2 and 3 show some important data on heart disease for the patients with CAD and valvular heart disease undergoing a definite cardiac procedure. The 2 patients not taken on cardiopulmonary bypass had the following characteristics: (1) two-vessel CAD, no previous myocardial infarction, stable angina, good left ventricular function, no mitral regurgitation, concomitant high-grade, and symptomatic stenosis of an internal carotid artery; (2) relevant aortic stenosis in combination with a two-vessel CAD, stable angina, NYHA classification II–III, good left ventricular function.


View this table:
[in this window]
[in a new window]
 
Table 2. Preoperative Characteristics of Disease in Patients With CAD (n = 30)

 

View this table:
[in this window]
[in a new window]
 
Table 3. Preoperative Characteristics of Disease in Patients With Valvular Disease (n = 13)

 
There was a multitude of coexistent diseases in the patients undergoing a cardiac operation. Coexistent diseases, present in more than 10% either in patients with CAD (n = 30) or in patients with valvular or combined disease (n = 13) were diabetes mellitus (27% in CAD/15% in valvular disease), arterial hypertension (83%/85%), hypercholesterinemia (27%/23%), history of smoking cigarettes within the last 6 months before cardiac operation (30%/31%), chronic obstructive pulmonary disease (17%/0%), peripheral vascular diseases (40%/0%), hyperparathyroidism (17%/23%), peptic ulcer disease (20%/8%), gout (3%/15%). A history of neoplasm was present in 6 patients (breast 1, metastatic prostate 1, colon 2, renal 2).

Renal failure was attributed to the following pathologic disorders (n = 45): polycystic disease of the kidney (7 patients), chronic glomerulonephritis (5), vascular renal disease (5), toxic (4), chronic pyelonephritis (4), diabetic nephropathy (3), lithiasis (3), history of nephrectomy due to neoplasm and subsequent nephritis of the contralateral kidney (2), gout nephropathy (1), unknown (8 patients). Three patients had undergone renal transplantation with subsequent failure of the donor kidney.

Renal dialysis
All cardiovascular procedures were done while the patients were on maintenance dialysis. The preoperative duration of dialysis varied widely (Table 1). Even those patients who underwent dialysis therapy for as short as 1 month before cardiovascular operation suffered from end-stage chronic renal disease, which had gradually deteriorated to become dialysis dependent. Only in 1 patient with toxic nephropathy renal function recovered significantly, and dialysis therapy was terminated 3 months after cardiac intervention (aortic valve replacement).

In accordance with end-stage renal disease, all patients had azotemia (prebypass level of blood urea nitrogen, 128 ± 8 mg/dL) and elevated creatinine levels (prebypass plasma creatinine, 7.9 ± 0.4 mg/dL).

The perioperative dialysis program consisted of the following procedures: dialysis the day before operation, hemodialysis during the cardiopulmonary bypass, and resumption of dialysis the first or the second day after operation. Hemodialysis was performed in all patients with the exception of 1 patient who was on chronic ambulatory peritoneal dialysis for 10 years and was treated by peritoneal dialysis pre- and postoperatively.

Operative management
Details concerning operation are given in Tables 4 and 5 . Coronary artery bypass grafting (CABG) was performed using cardiopulmonary bypass and moderate systemic hypothermia. Distal anastomoses were sutured on the fibrillating topically cooled heart during aortic cross-clamping. Proximal vein anastomosis were sutured to the ascending aorta partially excluded by a vascular clamp while the heart was beating and being rewarmed. Cardiac operations containing valvular surgery were performed using cold crystalloid cardioplegia.


View this table:
[in this window]
[in a new window]
 
Table 4. Surgical Management in Patients With CAD (n = 30)

 

View this table:
[in this window]
[in a new window]
 
Table 5. Surgical Management in Patients With Valvular Disease (n = 13)

 
Only mechanical valves were implanted (either Ultracor or St. Jude Medical valves). After valve replacement patients were put on phenprocoumon (Marcumar; Hoffmann-La Roche, Basel, Switzerland) and instructed to take anticoagulation for the rest of their lives. After CABG patients were put on phenprocoumon for 3 months.

Follow-up
Data for long-term follow-up were collected from patients’ medical records, from questionnaires sent to physicians and dialysis centers, and from telephone interviews with patients, relatives, and physicians. The follow-up was accomplished between December 1995 and February 1996. Minimum and maximum follow-up after operation was 16 and 72 months, respectively, with a mean follow-up of 36 months. Long-term follow-up was complete for all 45 consecutive patients.

Statistics
Actuarial analysis of long-term survival and cardiac event-free survival were calculated using the method of Kaplan and Meier. All data are expressed as mean ± standard error of the mean unless otherwise stated.


    Results
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 
Clinical outcomes
The overall 30-day mortality rate was 4.4% (2 of 45 patients). One death occurred in a 68-year-old patient with three-vessel CAD, a history of two previous myocardial infarctions, unstable angina, and a left ventricular ejection fraction < 40%. After initial uneventful recovery the patient died on the fifth postoperative day of unknown cause (dysrhythmia?, acute myocardial infarction?). The other death occurred in a 64-year-old patient with mixed mitral stenosis and incompetence, tricuspid incompetence and a three-vessel CAD with second degree (out of three) reduction of left ventricular function, NYHA classification III. After operation the patient died of multiorgan failure due to sustained inadequate cardiac output within the second week after operation. One more patient died on the 40th day after operation. This patient suffered from acute multivalvular endocarditis with cerebral emboli and mitral papillary muscle rupture. The patient was operated on an emergency basis, and an aortic valve reconstruction and a mitral valve replacement were performed. Eventually this patient died due to sepsis after colon gangrene and perforation with peritonitis (hospital mortality, 6.7%). The overall morbidity was 24% (11 of 45 patients). Details are shown in Table 6. All patients recovered completely from postoperative complications with the one exception of the above-mentioned patient who died on the 40th day after colon perforation with peritonitis. No patients required reoperation for mediastinal bleeding. For the 42 patients who were alive at the time of hospital discharge, maximal stay on our intensive care unit was 7 days; all patients left our department within 10 days and returned to their nephrologic centers for further convalescence.


View this table:
[in this window]
[in a new window]
 
Table 6. Complications After Cardiac Operation

 
Long-term survival, late mortality, and functional results
Among all patients (n = 45), the cumulative survival rates were approximately 0.8 at 1 year, 0.7 at 2 years, 0.6 at 3 years, and 0.5 at 5 years (Fig 1). Patients who underwent CABG had survival rates of 0.90, 0.73, 0.67, and 0.67 at 1, 2, 3, and 5 years, respectively. The survival rates were similar for patients who underwent a valvular operation, being 0.77, 0.77, 0.77, and 0.39 at 1, 2, 3, and 5 years, respectively (Fig 1).



View larger version (24K):
[in this window]
[in a new window]
 
Fig 1. Actuarial survival after operation for coronary artery disease (n = 30, solid circles) and for valvular disease (n = 13, solid triangles). Minimum follow-up was 16 months. Short and long vertical bars represent either 1 or 2 patients, who were lost to analysis, as they were alive at the time of follow-up.

 
The causes of late mortality (> 30 days) were due to cardiac disease in 7 patients and due to noncardiac disease in 6 patients. The interval between operation and death was 19 ± 4 months for cardiac-related death and 23 ± 8 months for noncardiac death (Table 7).


View this table:
[in this window]
[in a new window]
 
Table 7. Late Mortality After Cardiac Operation

 
Two patients subsequently underwent an interventional procedure: in 1 patient a coronary venous bypass thrombectomy was performed 11 months after CABG, and in the other patient a percutaneous transluminal coronary angioplasty was performed before renal transplantation.

Five patients received a renal transplantation 32 ± 9 months after cardiac operation, which was a CABG procedure in 4 patients.

Of the 20 patients surviving the CABG procedure, 12 were free from anginal pain after 36 ± 4 months, 6 patients had stable angina and 2 had unstable angina (Fig 2). The 2 patients, who deteriorated from stable to unstable angina, were alive 20 and 52 months after operation. Neither completeness of revascularization nor the use of arterial grafting were predictors of better functional results (not shown). Incomplete revascularization was formally defined as not all major vessels with severe arterial disease (either stenosed or occluded) having received a bypass grafting. Seven of the 8 patients surviving a valvular operation showed improved functional status 35 ± 5 months after operation (Fig 3). Only one 69-year-old patient went from NYHA class II to class III 32 months after aortic valve replacement due to increasing mitral regurgitation.



View larger version (22K):
[in this window]
[in a new window]
 
Fig 2. Late postoperative changes of ischemic symptoms after coronary artery bypass grafting in patients suffering from stable angina preoperatively (top) or unstable angina preoperatively (bottom). The numbers of patients are indicated.

 


View larger version (19K):
[in this window]
[in a new window]
 
Fig 3. Late postoperative changes of New York Heart Association (NYHA) functional class after valvular operation. The numbers of patients are indicated.

 
One of the 2 patients who were not taken on cardiopulmonary bypass was symptom-free with medical therapy 31 months after pericardiotomy. The other patient (with combined CAD and aortic valve stenosis) suffered from unstable angina and symptoms corresponding NYHA class III 32 months after pericardiotomy.


    Comment
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 
Patients on maintenance dialysis suffer from a broad spectrum of cardiovascular diseases. Approximately 30% to 50% of deaths in dialysis patients can be attributed to cardiovascular disease [5, 8, 12, 13] compared to less than 15% of deaths in an age-corrected control population [14]. It has been proposed that possibly some of the cardiac disorders might be aggravated by renal disease itself or by comorbid findings [15] associated with end-stage renal disease. For example, coronary heart disease is unusually prevalent in patients with end-stage renal disease, but nevertheless it still remains unclear whether the progress of CAD is accelerated in dialysis patients [10, 16, 17] compared to the general population. Also, valvular calcification may be accelerated in patients with chronic renal failure [7, 18] and septic events with endocarditis may be regarded as typical complication from long-term hemodialysis procedures [3, 6]. Only recently larger series of successful cardiac operations have been published [1, 46, 9, 11, 1820], and reports on long-term results after cardiac intervention are scarce [16, 11, 19, 20].

The perioperative risk of cardiac operation has been shown to be considerably increased in patients with maintenance hemodialysis compared to the general cardiac patient population, possibly due to a multitude of comorbid disorders like hypertension and diabetes mellitus, or due to advanced disease. Ko and colleagues [9] summarize the results of 296 cases of cardiopulmonary bypass procedures in dialysis patients in the literature and found an overall mortality of 9%. In series consisting of more than 20 patients the range of perioperative mortality was 3% to 25% (with a mean of 10%). The lethal risk of valvular operation and combined operation (7 deaths in 54 patients; mortality, 13%) was slightly higher than the risk of CABG (20 deaths in 236 patients; mortality, 8%). More recent studies are well in support to these findings; Owen and colleagues [1] observed at CABG in patients with dialysis-dependent renal failure a mortality rate of 9% and Kaul and associates [6] found a mortality of 11% at cardiac operations in patients with end-stage renal disease. The latter investigators state that a subgroup of patients undergoing a reoperation had a considerable higher mortality (29%; 2 of 7 patients), and all perioperative deaths occurred in patients who were in class IV cardiac heart failure preoperatively. Two further studies showed somewhat different results: one of these showed a mortality of 31% (4 of 13 patients) [21], most likely attributable to the mean age of 69 years, which was a decade older than in nearly all other reports (Table 8). The other study consisted of 23 patients undergoing CABG (mean age, 55 years) with no hospital death reported [11]. Our own experience with 2 perioperative deaths in 45 patients undergoing a cardiac operation (mortality, 4.4%) is well in line with the preceding studies. These 2 deaths and a further death in a patient who died on the 40th postoperative day occurred in patients with advanced diseases. This finding puts emphasis on the utmost importance of careful selection of dialysis-dependent patients.


View this table:
[in this window]
[in a new window]
 
Table 8. Long-Term Survival After Cardiac Operation in Dialysis Patients

 
Only few researchers studied the long-term survival in patients on maintenance dialysis undergoing cardiac operation. A summarization of these results are shown in Table 8. After 5 years, only approximately half of the patients are still alive (39% to 67%). This finding is not considerably different from patient populations on long-term hemodialysis not undergoing a cardiac procedure; a yearly mortality of 8% to 11% has been calculated and an actuarial mortality of approximately 40% after 5 years of hemodialysis [16, 22]. It could be speculated that patients who are operated on were initially at an increased risk and thereby candidates for operation. But, there are no data available concerning the natural history of such a subgroup of patients who are potential candidates for cardiac operation, but not operated on (medically treated). In the present series there are 2 patients who were assigned to a cardiac operation, but the operation aborted because of extreme calcification of the ascending aorta. These 2 patients were still alive after 31 and 32 months, showing that at least in individual cases long-term survival does obviously exist in such a subgroup of patients assigned to a cardiac operation but not operated on. Interestingly, in the long-term follow-up 7 of 13 patients died on cardiac causes and 6 on noncardiac causes as would have been expected from natural history in patients on maintenance hemodialysis [12, 13, 23]. Thus, it is not proven, by our study or studies done by other investigators, that cardiac operation does in fact prolong life expectancy in patients with dialysis-dependent renal failure, although there is reliable evidence. A similar long-term survival in the population of patients operated on and the general population of dialysis patients indicates that such a therapeutic benefit exists, as the patients operated on had proven cardiovascular disease at the time of operation and conceivably a worse life expectancy than the general population of dialysis patients.

Does cardiac operation improve life quality in patients on long-term dialysis with cardiac disease and what factors might determine long-term functional outcome? Fifteen of 20 patients (75%) with CAD showed pronounced symptomatic improvement still 3 years after CABG compared to the preoperative evaluation, only 2 of 20 patients (10%) showed deterioration. Completeness of revascularization did not seem to be of importance in our series. Furthermore, patients with arterial grafting did not do better in our series than those with complete venous grafting. In fact, 2 of 5 patients (40%) with arterial grafting worsened. However, the low number of patients and the fact that no postoperative angiograms were performed to examine the patency of venous or arterial grafts rules out any further conclusions. Less than complete revascularization has also been addressed by Koyanagi and colleagues [11]. These investigators emphasize that incomplete revascularization is because most patients on chronic hemodialysis are known to have extensive coronary disease. As well as having a large number of lesions in each vessel, such patients show diffuse and calcified lesions and poor distal runoff, obliging to perform less than complete revascularization. All but one long-term survivor improved after valvular or combined cardiac operation and they were in good NYHA state on the average 3 years after the operation (Fig 3). Other long-term results on dialysis patients with valvular operations are missing.

In conclusion, cardiovascular operations can be performed with good short-term and long-term results in patients with renal failure dependent on chronic dialysis, provided a carefully selection of the patients is assured. Patients more than 70 years of age and patients with advanced cardiac diseases and poor ventricular function might be excluded from operation because they do not gain a benefit from cardiovascular operation. Their perioperative risk seems consistently to be increased [9, 21], and the long-term outcome is significantly decreased [6]. But with the exception of these high-risk patients, the life expectancy of dialysis patients undergoing a cardiac operation can be approximated to the life expectancy of the general patient population on maintenance dialysis. Cardiac events can be reliably prevented and valvular or endocarditic lesions can be successfully repaired. Our study demonstrates that in the long-term course anginal pain is being relieved in most patients with coronary artery disease and functional status according to the NYHA classification is improved in patients with valvular and combined diseases. Cardiac operation may be a prerequisite before renal transplantation.


    References
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 

  1. Owen C.H., Cummings R.G., Sell T.L., Schwab S.J., Jones R.H., Glower D.D. Coronary artery bypass grafting in patients with dialysis-dependent renal failure. Ann Thorac Surg 1994;58:1729-1733.[Abstract]
  2. Marshall J.W.G., Rossi N.P., Meng R.L., Wedige-Stecher T. Coronary artery bypass grafting in dialysis patients. Ann Thorac Surg 1986;42:S12-S15.
  3. Zamora J.L., Burdine J.T., Karlberg H., Shenaq S.M., Noon G.P. Cardiac surgery in patients with end-stage renal disease. Ann Thorac Surg 1986;42:113-117.[Abstract]
  4. Opsahl J.A., Husebye D.G., Helseth H.K., Collins A.J. Coronary artery bypass surgery in patients on maintenance dialysis. Am J Kidney Dis 1988;12:271-274.[Medline]
  5. Batiuk T.D., Kurtz S.B., Oh J.K., Orszulak T.A. Coronary artery bypass operation in dialysis patients. Mayo Clin Proc 1991;66:45-53.[Medline]
  6. Kaul T.K., Fields B.L., Reddy M.A., Kahn D.R. Cardiac operations in patients with end-stage renal disease. Ann Thorac Surg 1994;57:691-696.[Abstract]
  7. Depace N.L., Rohrer A.H., Kotler M.N., Brezin J.H., Parry W.R. Rapidly progressive massive mitral annular calcification occurring in a patient with chronic renal failure. Arch Intern Med 1981;141:1663-1665.[Abstract]
  8. Rostand S.G., Rutsky E.A. Cardiac disease in dialysis patients. In: Nissenson A.R., Fine R.N., Gentile D.E., eds. Clinical dialysis, 2nd ed. Norwalk, CT: Appleton-Lange, 1990:409-446.
  9. Ko W., Kreiger K.H., Isom O.W. Cardiopulmonary bypass procedures in dialysis patients. Ann Thorac Surg 1993;55:677-684.[Abstract]
  10. Lundin A.P., Adler A.J., Feinroth M.V., Berlyne G.M., Friedman E.A. Maintenance hemodialysis. JAMA 1980;244:38-40.[Abstract]
  11. Koyanagi T., Nishida H., Kitamura M., et al. Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients. Ann Thorac Surg 1996;61:1793-1796.[Abstract/Free Full Text]
  12. Hellerstedt W.L., Johnson W.J., Ascher N., et al. Survival rates of 2,728 patients with end-stage renal disease. Mayo Clin Proc 1984;59:776-783.[Medline]
  13. Brunner F.P., Brynger H., Chantler C., et al. Combined report on dialysis and transplantation in Europe, IX, 1978. Proc Eur Dial Transplant Assoc 1979;16:4-73.[Medline]
  14. Pastan S.O., Braunwald E. Renal disorders and heart disease. In: Braunwald E., ed. Heart disease. A textbook of cardiovascular medicine. Philadelphia, PA: Saunders, 1988:1828-1847.
  15. Friedman H.S., Shah B.N., Kim H.J.G., Bove L.A., Del Monte M.M., Smith A.J. Clinical study of the cardiac findings in patients with chronic maintenance hemodialysis. Clin Nephrol 1981;16:75-85.[Medline]
  16. Lindner A., Charra B., Sherrard D.J., Scribner B.H. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
  17. Nicholls A.J., Catto G.R.D., Edward N., Engeset J., MacLeod M. Accelerated atherosclerosis in long-term dialysis and renal-transplant patients. Lancet 1980;1:276-278.[Medline]
  18. Monson B.K., Wickstrom P.H., Haglin J.J., Francis G., Comty C.M., Helseth H.K. Cardiac operation and end-stage renal disease. Ann Thorac Surg 1980;30:267-272.[Abstract]
  19. Blakeman B.M., Pifarré R., Sullivan H.J., Montoya A., Bakhos M. Cardiac surgery for chronic renal dialysis patients. Chest 1989;95:509-511.[Abstract/Free Full Text]
  20. Grabensee B., Ivens K., Krian A. Extrakardiale Risikofaktoren in der Herzchirurgie—Niere. Z Kardiol 1990;79(suppl 4):47-57.
  21. Samuels L.E., Sharma S., Morris R.J., et al. Coronary artery bypass grafting in patients with chronic renal failure. J Card Surg 1996;11:128-133.[Medline]
  22. Burton B.T., Krueger K.K., Bryan F.A. National registry of long-term dialysis patients. JAMA 1971;218:718-722.[Medline]
  23. US Renal Data System. USRDS 1991 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1991.
Accepted for publication March 15, 1999.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. B. Rahmanian, D. H. Adams, J. G. Castillo, J. Vassalotti, and F. Filsoufi
Early and late outcome of cardiac surgery in dialysis-dependent patients: Single-center experience with 245 consecutive patients.
J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 915 - 922.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
F. Filsoufi, P. B. Rahmanian, J. G. Castillo, J. Chikwe, A. Carpentier, and D. H. Adams
Early and late outcomes of cardiac surgery in patients with moderate to severe preoperative renal dysfunction without dialysis
Interactive CardioVascular and Thoracic Surgery, February 1, 2008; 7(1): 90 - 95.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
N. Boku, M. Masuda, M. Eto, T. Nishida, S. Morita, and R. Tominaga
Risk Evaluation and Midterm Outcome of Cardiac Surgery in Patients on Dialysis
Asian Cardiovasc Thorac Ann, February 1, 2007; 15(1): 19 - 23.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
V. Chan, W.R. E. Jamieson, A. G. Fleisher, D. Denmark, F. Chan, and E. Germann
Valve Replacement Surgery in End-Stage Renal Failure: Mechanical Prostheses Versus Bioprostheses.
Ann. Thorac. Surg., March 1, 2006; 81(3): 857 - 862.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Nakasuji, S. Nishi, K. Nakasuji, N. Hamaoka, K. Ikeshita, and A. Asada
Duration of Dialysis Is a Significant Predictor of Prolonged Postoperative Mechanical Ventilation in Dialysis-Dependent Patients Undergoing Cardiac Surgery
Anesth. Analg., January 1, 2006; 102(1): 2 - 7.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Witczak, A. Hartmann, and J. L. Svennevig
Multiple Risk Assessment of Cardiovascular Surgery in Chronic Renal Failure Patients
Ann. Thorac. Surg., April 1, 2005; 79(4): 1297 - 1302.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
K. Miyahara, M. Maeda, H. Sakurai, M. Nakayama, H. Murayama, and H. Hasegawa
Cardiovascular surgery in patients on chronic dialysis: effect of intraoperative hemodialysis
Interactive CardioVascular and Thoracic Surgery, March 1, 2004; 3(1): 148 - 152.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Shibata, Y. Sasaki, K. Hattori, H. Hirai, M. Hosono, H. Fujii, and S. Suehiro
Sonoclot analysis in cardiac surgery in dialysis-dependent patients
Ann. Thorac. Surg., January 1, 2004; 77(1): 220 - 225.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Penta de Peppo, P. Nardi, R. De Paulis, A. Pellegrino, S. Forlani, A. Scafuri, and L. Chiariello
Cardiac surgery in moderate to end-stage renal failure: analysis of risk factors
Ann. Thorac. Surg., August 1, 2002; 74(2): 378 - 383.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. A. Herzog, J. Z. Ma, and A. J. Collins
Long-Term Survival of Dialysis Patients in the United States With Prosthetic Heart Valves: Should ACC/AHA Practice Guidelines on Valve Selection Be Modified?
Circulation, March 19, 2002; 105(11): 1336 - 1341.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
E. Prifti, M. Bonacchi, M. Leacche, G. Frati, G. Giunti, P. Proietti, A. M. Cricco, G. Brancaccio, B. Furci, A. Baboci, et al.
Myocardial Revascularization in Chronic Renal Failure: 10-year Experience
Asian Cardiovasc Thorac Ann, September 1, 2001; 9(3): 176 - 181.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Hosoda, T. Yamamoto, K. Takazawa, M. Yamasaki, S. Yamamoto, I. Hayashi, and K. Kudoh
Coronary artery bypass grafting in patients on chronic hemodialysis: surgical outcome in diabetic nephropathy versus nondiabetic nephropathy patients
Ann. Thorac. Surg., February 1, 2001; 71(2): 543 - 548.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Y. Liu, N. J. O. Birkmeyer, J. H. Sanders, J. R. Morton, H. F. Henriques, S. J. Lahey, R. W. Dow, C. Maloney, A. W. DiScipio, R. Clough, et al.
Risks of Morbidity and Mortality in Dialysis Patients Undergoing Coronary Artery Bypass Surgery
Circulation, December 12, 2000; 102(24): 2973 - 2977.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael Frenken
Arno Krian
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frenken, M.
Right arrow Articles by Krian, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frenken, M.
Right arrow Articles by Krian, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS